These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18309579)

  • 41. Seasonal trivalent influenza vaccine for 2010-2011.
    Med Lett Drugs Ther; 2010 Oct; 52(1348):77-9. PubMed ID: 20885341
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing.
    Ambrose CS
    Hum Vaccin Immunother; 2012 Feb; 8(2):279; author reply 280. PubMed ID: 22426366
    [No Abstract]   [Full Text] [Related]  

  • 43. Update: Influenza activity--United States and worldwide, 2006-07 season, and composition of the 2007-08 influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Aug; 56(31):789-94. PubMed ID: 17687244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
    [No Abstract]   [Full Text] [Related]  

  • 45. Update: influenza activity--United States and worldwide, May 22-September 3, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Sep; 60(36):1239-42. PubMed ID: 21918493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].
    Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2138-44. PubMed ID: 18856032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The contents of the syringe.
    Salzberg S
    Nature; 2008 Jul; 454(7201):160-1. PubMed ID: 18615063
    [No Abstract]   [Full Text] [Related]  

  • 49. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update: influenza activity --- United States, October 3-December 11, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Dec; 59(50):1651-5. PubMed ID: 21178950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza vaccination for older adults.
    Talbot HK; Libster R; Edwards KM
    Hum Vaccin Immunother; 2012 Jan; 8(1):96-101. PubMed ID: 22252003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 54. Influenza guideline for South Africa--update 2008.
    Green RJ; Feldman C; Schoub B; Richards GA; Madhi SA; Zar HJ; Lalloo U; ; Klugman K; Phillips D; Cameron NA; Eggers RR
    S Afr Med J; 2008 Mar; 98(3 Pt 2):224-30. PubMed ID: 18652399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recommendations for prevention and control of influenza in children, 2013-2014.
    Committee on infectious diseases
    Pediatrics; 2013 Oct; 132(4):e1089-104. PubMed ID: 23999962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recommended composition of influenza virus vaccines for use in the 1999-2000 season.
    Wkly Epidemiol Rec; 1999 Feb; 74(8):57-61. PubMed ID: 10079754
    [No Abstract]   [Full Text] [Related]  

  • 57. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
    Manuel O; Humar A; Berutto C; Ely L; Giulieri S; Lien D; Meylan PR; Weinkauf J; Pascual M; Nador R; Aubert JD; Kumar D
    J Heart Lung Transplant; 2011 Jun; 30(6):679-84. PubMed ID: 21377898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influenza vaccination and anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Wiwanitkit V
    Nephrology (Carlton); 2015 Jul; 20(7):511-2. PubMed ID: 26063490
    [No Abstract]   [Full Text] [Related]  

  • 60. Here comes influenza season.
    Shulman ST
    Pediatr Ann; 2012 Nov; 41(11):440-1. PubMed ID: 23814925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.